Launch Tech Co Ltd Stock
Your prediction
Pros and Cons of Launch Tech Co Ltd in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Launch Tech Co Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Launch Tech Co Ltd | 2.720% | 2.000% | 2.000% | -42.481% | -18.790% | 232.609% | 77.907% |
| Chongqing Machinery & Electric Co Ltd | -2.530% | -1.000% | -8.333% | 31.126% | -5.714% | 241.379% | 325.806% |
| Jenoptik AG | 1.570% | -13.677% | -24.197% | 77.446% | 76.086% | 17.691% | 19.404% |
| Tennant Co. | 1.640% | 3.467% | -3.182% | 8.531% | 22.205% | - | - |
News
Ionis Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Ionis Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose to $268 million, with commercial revenue reaching $119 million, driven
A $1T Black Hole: SpaceX Eyes Pentagon AI to Break Free
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- SpaceX shares have fallen below their $135 IPO price, erasing over $1 trillion in implied market value amid concerns about
Celcuity Enters Commercial Stage as FDA Approves REVTORPYK for Advanced Breast Cancer
Key Points
- Interested in Celcuity, Inc.? Here are five stocks we like better.
- Celcuity won full FDA approval for gedatolisib, now branded REVTORPYK, in a specific advanced breast cancer